Evista (raloxifene hydrochloride)

Company
Eli Lilly

Approval Status
Approved September 1999

Treatment for
For the treatment of osteoporosis in postmenopausal women.

Possible similar drugs
Evista; Evista

Areas
Diabetes / Endocrinology , Musculoskeletal , Pregnancy & Gynecology

Tablet of raloxifene hydrochloride for the treatment of osteoporosis in post-menopausal women.

Tablet, 60 mg.

Evista (raloxifene hydrochloride) Drug Information

The Evista (raloxifene hydrochloride) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top